Utility of bevacizumab in advanced hepatocellular carcinoma: A veterans affairs experience by Max M. Wattenberg, Nevena Damjanov, David E. Kaplan

Get full text

Systemic inflammation is a determinant of outcomes of CD40 agonist–based therapy in pancreatic cancer patients by Max M. Wattenberg, Veronica M. Herrera, Michael A. Giannone, Whitney L. Gladney, Erica L. Carpenter, Gregory L. Beatty

Get full text

Kupffer cells prevent pancreatic ductal adenocarcinoma metastasis to the liver in mice by Stacy K. Thomas, Max M. Wattenberg, Shaanti Choi-Bose, Mark Uhlik, Ben Harrison, Heather Coho, Christopher R. Cassella, Meredith L. Stone, Dhruv Patel, Kelly Markowitz, Devora Delman, Michael Chisamore, Jeremy Drees, Nandita Bose, Gregory L. Beatty

Get full text